Announce Date | 12/31/1969 |
EPS Normalized Actual | $ In Line |
EPS GAAP Actual | $ In Line |
Revenue Actual | $0.048959B |
Revenue Surprise | Beat by $48.959M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.05786 |
EPS GAAP Estimate | $-0.05786 |
Revenue Estimate | $0.077668815B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 0.016449 | 54.1 | 0.01237045 | 0.02073304 | 1 |
Dec 2026 | 0 | INF | 0 | 0 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.11 | -0.11 | 0.048959B | 100% | -3.65M |
FQ4 2024 (Dec 2024) | 0 | 0 | 0.042223B | -2.83% | 2.81M |
FQ3 2024 (Sep 2024) | -0.2608 | -0.187819 | 0.024102B | -25.73% | -3.96M |
FQ2 2024 (Jun 2024) | -0.0486 | -0.008704 | 0.036808B | 15.17% | -1.32M |
FQ1 2024 (Mar 2024) | 0.13 | 0.129065 | 0B | -INF% | -50.26M |
FQ4 2023 (Dec 2023) | 0.0386 | 0.0386 | 0.043419B | 93.01% | 43.42M |
FQ3 2023 (Sep 2023) | -0.0703 | -0.024047 | 0.030304B | 100% | -3.19M |
FQ1 2021 (Mar 2021) | 0 | 0 | 0B | NAN% | 0M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
-0.05786
Consensus Revenue Estimates
0.077668815B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.004726 | -- | 0.00359874 | 0.00645166 | 1 |
FQ2 2027 (Jun 2027) | 0.030237 | -- | 0.02302476 | 0.04127776 | 1 |
FQ1 2027 (Mar 2027) | 0.040119 | -- | 0.03054967 | 0.05476808 | 1 |
FQ3 2026 (Sep 2026) | -0.010624 | -- | -0.01450326 | -0.00808992 | 1 |
FQ2 2026 (Jun 2026) | -0.008959 | -- | -0.0122303 | -0.00682207 | 1 |
FQ1 2026 (Mar 2026) | 0.005852 | 1979.7 | 0.00445616 | 0.0079888 | 1 |
FQ3 2025 (Sep 2025) | -0.05786 | -350.74 | -0.07898705 | -0.04405902 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.16B | -- | 0.13B | 0.21B | 9 |
FQ2 2027 (Jun 2027) | 0.16B | -- | 0.13B | 0.21B | 6 |
FQ1 2027 (Mar 2027) | 0.15B | -- | 0.13B | 0.2B | 5 |
FQ3 2026 (Sep 2026) | 0.12B | -- | 0.1B | 0.16B | 8 |
FQ2 2026 (Jun 2026) | 0.12B | -- | 0.09B | 0.15B | 5 |
FQ1 2026 (Mar 2026) | 0.11B | 56.15 | 0.09B | 0.14B | 5 |
FQ3 2025 (Sep 2025) | 0.08B | 68.97 | 0.06B | 0.1B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
4
EPS # of in-lines
2
Revenue # of Beats
2
Revenue # of Misses
5
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0 | -0.11 | -0.11 | 100% |
FQ4 2024 (Dec 2024) | 0 | 0 | 0 | NAN% |
FQ3 2024 (Sep 2024) | -0.072981 | -0.2608 | -0.187819 | 72.02% |
FQ2 2024 (Jun 2024) | -0.039896 | -0.0486 | -0.008704 | 17.91% |
FQ1 2024 (Mar 2024) | 0.000935 | 0.13 | 0.129065 | 99.28% |
FQ4 2023 (Dec 2023) | 0.0386 | 0.0386 | 100% | |
FQ3 2023 (Sep 2023) | -0.046253 | -0.0703 | -0.024047 | 34.21% |
FQ1 2021 (Mar 2021) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.05B | $0.05B | $-3.65M | -7.46% |
FQ4 2024 (Dec 2024) | $0.04B | $0.04B | $2.81M | 6.66% |
FQ3 2024 (Sep 2024) | $0.03B | $0.02B | $-3.96M | -16.42% |
FQ2 2024 (Jun 2024) | $0.04B | $0.04B | $-1.32M | -3.58% |
FQ1 2024 (Mar 2024) | $0.05B | $0B | $-50.26M | -INF% |
FQ4 2023 (Dec 2023) | $0B | $0.04B | $43.42M | 100% |
FQ3 2023 (Sep 2023) | $0.03B | $0.03B | $-3.19M | -10.54% |
FQ1 2021 (Mar 2021) | $0B | $0B | $0M | NAN% |